1933 Industries Inc. (CNSX: TGIF)
Health Care · Pharmaceuticals · CA
CA$0.01
+100.00% today · 0.0% 1Y
1933 Industries Inc. (CNSX: TGIF) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.78M and employs 85 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.01 and 0.02.
Tweenvest scores 1933 Industries Inc. across four factors: quality 41/100, value 52/100, growth 50/100. Its strongest factor is value.
TGIF price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.78M
- Revenue (TTM)
- $12.13M
- P/E
- 10.72
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 1.60
- 52-week high
- CA$0.02
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 520.76M
- Employees
- 85
- Next earnings
- —
About 1933 Industries Inc.
1933 Industries Inc. is a Vancouver, Canada-based cannabis company engaged in the cultivation and production of cannabis products throughout the United States and Canada. The firm develops, packages, and markets an extensive range of cannabidiol (CBD)-infused items, catering to both the medical and recreational cannabis sectors. Under its Canna Hemp and Canna Hemp X brands, these CBD offerings include tinctures, vape pens, cartridges, topical lotions, pain creams, gummies, and capsules. Beyond CBD, the company also supplies traditional cannabis flowers and concentrates. Consumers can acquire its CBD-infused products via retail dispensaries, other retail establishments, and its dedicated e-commerce platform. The company officially changed its name from Friday Night Inc. to 1933 Industries Inc. in September 2018.
- ISIN
- CA65442F1053
- Listed since
- Feb 9, 2009
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.58 | +0.05% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.39 | -0.60% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.23 | +0.38% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.